120 related articles for article (PubMed ID: 21928002)
1. Exacerbation of radiation fibrosis with erlotinib: another pattern of radiation recall phenomenon.
Arakawa H; Johkoh T; Sakai F; Kusumoto M; Hataji O; Taguchi O
Jpn J Radiol; 2011 Oct; 29(8):587-9. PubMed ID: 21928002
[TBL] [Abstract][Full Text] [Related]
2. A case of radiation recall pneumonitis induced by erlotinib, which can be related to high plasma concentration.
Togashi Y; Masago K; Mishima M; Fukudo M; Inui K
J Thorac Oncol; 2010 Jun; 5(6):924-5. PubMed ID: 20502274
[No Abstract] [Full Text] [Related]
3. Fatal interstitial lung disease after erlotinib administration in a patient with radiation fibrosis.
Um SJ; Lee SK; Yang DK; Son C; Roh MS; Kim KN; Lee KN; Choi PJ
Clin Respir J; 2009 Jul; 3(3):181-4. PubMed ID: 20298401
[TBL] [Abstract][Full Text] [Related]
4. Radiation recall gastritis secondary to erlotinib in a patient with pancreatic cancer.
Graziani C; Hegde S; Saif MW
Anticancer Res; 2014 Dec; 34(12):7339-43. PubMed ID: 25503169
[TBL] [Abstract][Full Text] [Related]
5. Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment--case report.
Hsieh CH; Chang HT; Lin SC; Chen YJ; Wang LY; Hsieh YP; Chen CA; Chong NS; Lin SL; Chen CY; Shueng PW
BMC Cancer; 2010 Dec; 10():696. PubMed ID: 21194444
[TBL] [Abstract][Full Text] [Related]
6. Erlotinib-induced rash spares previously irradiated skin.
Lips IM; Koster ME; Houwing RH; Vonk EJ
Strahlenther Onkol; 2011 Aug; 187(8):499-501. PubMed ID: 21789741
[TBL] [Abstract][Full Text] [Related]
7. Temporal dependence of the effect of radiation on erlotinib-induced skin rash.
Lacouture ME; Hwang C; Marymont MH; Patel J
J Clin Oncol; 2007 May; 25(15):2140; author reply 2141. PubMed ID: 17513824
[No Abstract] [Full Text] [Related]
8. Interstitial lung disease following erlotinib (Tarceva) in a patient who previously tolerated gefitinib (Iressa).
Tammaro KA; Baldwin PD; Lundberg AS
J Oncol Pharm Pract; 2005 Sep; 11(3):127-30. PubMed ID: 16390601
[TBL] [Abstract][Full Text] [Related]
9. Fatal asymmetric interstitial lung disease after erlotinib for lung cancer.
Ren S; Li Y; Li W; Zhao Z; Jin C; Zhang D
Respiration; 2012; 84(5):431-5. PubMed ID: 22889962
[TBL] [Abstract][Full Text] [Related]
10. [Radiation recall pneumonitis induced by Gefitinib (Iressa): a case report].
Miya T; Ono Y; Tanaka H; Koshiishi Y; Goya T
Nihon Kokyuki Gakkai Zasshi; 2003 Aug; 41(8):565-8. PubMed ID: 14503345
[TBL] [Abstract][Full Text] [Related]
11. Radiation recall pneumonitis induced by erlotinib after palliative thoracic radiotherapy for lung cancer: Case report and literature review.
Awad R; Nott L
Asia Pac J Clin Oncol; 2016 Mar; 12(1):91-5. PubMed ID: 26846159
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of erlotinib related uveitis.
Kumar I; Ali K; Usman-Saeed M; Saeed MU
BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22892235
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary toxicity associated with erlotinib.
Liu V; White DA; Zakowski MF; Travis W; Kris MG; Ginsberg MS; Miller VA; Azzoli CG
Chest; 2007 Sep; 132(3):1042-4. PubMed ID: 17873198
[TBL] [Abstract][Full Text] [Related]
14. Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer.
Nanda A; Dias-Santagata DC; Stubbs H; O'Hara CJ; Zaner KS; Lynch TJ; Willers H
Clin Lung Cancer; 2008 Sep; 9(5):285-7. PubMed ID: 18824451
[TBL] [Abstract][Full Text] [Related]
15. Erlotinib-induced generalized eczema craquelé and follicular rash sparing the previous radiation field.
Chiu HY; Cheng YP; Jee SH; Tsai TF
Clin Exp Dermatol; 2012 Dec; 37(8):922-4. PubMed ID: 22731795
[No Abstract] [Full Text] [Related]
16. Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer.
Makris D; Scherpereel A; Copin MC; Colin G; Brun L; Lafitte JJ; Marquette CH
BMC Cancer; 2007 Aug; 7():150. PubMed ID: 17683587
[TBL] [Abstract][Full Text] [Related]
17. Both gefitinib and erlotinib induced drug-related interstitial lung disease in a patient with pulmonary adenocarcinoma.
Wang KF; Chang CY; Chang SC; Liu YC; Yuan MK; Yang YH
J Chin Med Assoc; 2013 Mar; 76(3):173-5. PubMed ID: 23497972
[TBL] [Abstract][Full Text] [Related]
18. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
[TBL] [Abstract][Full Text] [Related]
19. Erlotinib-associated trichomegaly.
Lane K; Goldstein SM
Ophthalmic Plast Reconstr Surg; 2007; 23(1):65-6. PubMed ID: 17237698
[TBL] [Abstract][Full Text] [Related]
20. Safety of erlotinib treatment in outpatients with previously treated non-small-cell lung cancer in Japan.
Nagai H; Tanaka S; Niimi M; Seo N; Sasaki T; Date H; Mishima M; Yasuda H; Yanagihara K
Int J Clin Oncol; 2011 Oct; 16(5):560-7. PubMed ID: 21625893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
